Delivery Order SPE2DB20D1100-SPE2DB25FC9R8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,059.87 to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity. The contract is classified as a firm fixed price delivery order with an ultimate completion date of May 28, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Briviact 10 mg/ml oral solution in a 300 ml quantity, with a ceiling value of $1,861.78. This is a firm fixed-price delivery order with no set-aside designation, executed on a competitive basis. The contract is set to reach ultimate completion by June 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $9,544.90 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity. This contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the vendor based on capability and pricing. The performance location is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity, with a ceiling value of $2,116.72. This competitively awarded, firm fixed-price delivery order is set to be completed by August 13, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $7,234.61 delivery order to AmerisourceBergen Drug Corp for Briviact 10 mg/ml oral solution (300ml) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Briviact 10 mg/ml oral solution in a 300 ml quantity. This non-competitive delivery order carries a ceiling value of $5,097.53 and represents a firm fixed price contract with an ultimate completion date of September 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $3,720.51 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for Briviact 10 mg/ml oral solution (300 ml), with an ultimate completion date of July 15, 2025. This is a firm fixed-price, non-set-aside contract executed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $3,601.40 to AmerisourceBergen Drug Corp for Briviact 10 mg/mL oral solution (300mL) on August 28, 2025, with completion due by August 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity, with a ceiling value of $9,298.44. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion by July 30, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $7,488.40 to AmerisourceBergen Drug Corp for the supply of Briviact 50 mg tablets (60-count units) on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC9R8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,047.30 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Briviact 10 mg/mL oral solution (300 mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 20, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive pharmaceutical and medical supply support to military healthcare systems and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. The Briviact order represents a typical transaction within this expansive framework, demonstrating AmerisourceBergen's role as a critical vendor for specialized pharmaceutical products across multiple therapeutic domains in support of Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 6/18/25 |